<div id="readability-page-1"><div><p>InnoCare Pharma Limited reported earnings results for the nine months ended September 30, 2025. For the nine months, the company reported sales was CNY 1,115.33 million compared to CNY 697.75 million a year ago. Net loss was CNY 64.41 million compared to CNY 275.41 million a year ago.</p><p>Basic loss per share from continuing operations was CNY 0.04 compared to CNY 0.16 a year ago. Diluted loss per share from continuing operations was CNY 0.04 compared to CNY 0.16 a year ago.</p></div></div>

諾誠健華-U

諾誠健華

<p>諾誠健華有限公司公佈了截至 2025 年 9 月 30 日的九個月財報。該公司在這九個月內的銷售額為 11.1533 億元人民幣，而去年同期為 6.9775 億元人民幣。淨虧損為 6441 萬元人民幣，而去年同期為 2.7541 億元人民幣。持續經營業務的基本每股虧損為 0.04 元人民幣，而去年同期為 0.16 元人民幣。持續經營業務的攤薄每股虧損為 0.04 元人民幣，而去年同期為 0.16 元人民幣</p>

諾誠健華有限公司公佈了截至2025年9月30日的九個月財務業績